Absence of Association between Methylene Blue Reduced Susceptibility and Polymorphisms in 12 Genes Involved in Antimalarial Drug Resistance in African <em>Plasmodium falciparum</em>
Half the human population is exposed to malaria. <i>Plasmodium falciparum</i> antimalarial drug resistance monitoring and development of new drugs are major issues related to the control of malaria. Methylene blue (MB), the oldest synthetic antimalarial, is again a promising drug after t...
Main Authors: | Mathieu Gendrot, Océane Delandre, Marie Gladys Robert, Francis Tsombeng Foguim, Nicolas Benoit, Rémy Amalvict, Isabelle Fonta, Joel Mosnier, Marylin Madamet, Bruno Pradines, on behalf of the French National Reference Centre for Imported Malaria Study Group |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/14/4/351 |
Similar Items
-
Prevalence of Mutations in the <i>pfcoronin</i> Gene and Association with Ex Vivo Susceptibility to Common Quinoline Drugs against <i>Plasmodium falciparum</i>
by: Océane Delandre, et al.
Published: (2021-08-01) -
Prevalence of mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, and association with ex vivo susceptibility to common anti-malarial drugs against African Plasmodium falciparum isolates
by: Francis Tsombeng Foguim, et al.
Published: (2020-06-01) -
In Vitro Evaluation of the Antiviral Activity of Methylene Blue Alone or in Combination against SARS-CoV-2
by: Mathieu Gendrot, et al.
Published: (2021-07-01) -
The in vivo antimalarial activity of methylene blue combined with pyrimethamine, chloroquine and quinine
by: Giovanny Garavito, et al.
Published: (2012-09-01) -
The D113N mutation in the RING E3 ubiquitin protein ligase gene is not associated with ex vivo susceptibility to common anti-malarial drugs in African Plasmodium falciparum isolates
by: Mathieu Gendrot, et al.
Published: (2018-03-01)